Henry Schein, Inc. (NASDAQ:HSIC) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company announced the completion of a $250 million strategic investment by funds ...

Henry Schein reaffirmed its adjusted annual profit forecast of $4.80 to $4.94 per share, compared with analysts' average estimate of $4.86 per share, according to data compiled by LSEG.

So, based on the above formula, the ROE for Henry Schein is: 8.2% = US$398m ÷ US$4.8b (Based on the trailing twelve months to December 2024). The 'return' is the yearly profit.

The notorious BlackCat ransomware actor appears to have claimed another high-profile victim after Fortune 500 healthcare organization Henry Schein was hit. As reported by BleepingComputer, the ...

Henry Schein, Inc. will release its first quarter 2025 financial results before the stock market opens on Monday, May 5th, 2025, and will provide a live webcast of its earnings conference call on ...

Henry Schein (HSIC) stock drops as Stifel downgrades the company to Hold, citing market share losses to online vendors in dental consumables. Read more here.

Analysts have recently evaluated Henry Schein and provided 12-month price targets. The average target is $79.0, accompanied by a high estimate of $86.00 and a low estimate of $75.00.

Henry Schein, Inc. (NASDAQ:HSIC) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company announced the completion of a $250 million strategic investment by ...